Atalanta Sosnoff Capital Has Cut Boston Scientific (BSX) Position; Verisk Analytics (VRSK) Sentiment Is 1.03

Verisk Analytics, Inc. provides data analytics solutions for clients in the insurance, natural resources, healthcare, financial services, and risk management markets in the United States and internationally. The company has market cap of $15.70 billion. The companyÂ’s Risk Assessment segment offers solutions to property and casualty insurance clients and focuses on prediction of loss, and selection and pricing of risk. It has a 35.05 P/E ratio. The Company’s solutions include industry-standard insurance programs that help P&C insurers in defining coverage and issue policies; actuarial services to help its clients analyze and price their risks; and customized services that include assisting with the development of independent insurance programs, analysis of their own underwriting experience, development of classification systems and rating plans, and other business decisions, as well as supplies information to various clients in other markets.

Atalanta Sosnoff Capital Llc decreased Boston Scientific Corp (BSX) stake by 1.7% reported in 2017Q3 SEC filing. Atalanta Sosnoff Capital Llc sold 21,031 shares as Boston Scientific Corp (BSX)’s stock rose 4.02%. The Atalanta Sosnoff Capital Llc holds 1.22M shares with $35.54M value, down from 1.24 million last quarter. Boston Scientific Corp now has $34.47 billion valuation. The stock decreased 0.16% or $0.04 during the last trading session, reaching $25.1. About 5.36 million shares traded. Boston Scientific Corporation (NYSE:BSX) has risen 19.12% since December 23, 2016 and is uptrending. It has outperformed by 2.42% the S&P500.

The stock decreased 0.26% or $0.25 during the last trading session, reaching $95.33. About 656,660 shares traded. Verisk Analytics, Inc. (VRSK) has risen 4.02% since December 23, 2016 and is uptrending. It has underperformed by 12.68% the S&P500.

Since January 1, 0001, it had 1 buying transaction, and 10 selling transactions for $16.85 million activity.

Analysts await Verisk Analytics, Inc. (NASDAQ:VRSK) to report earnings on February, 20. They expect $0.77 earnings per share, down 3.75% or $0.03 from last year’s $0.8 per share. VRSK’s profit will be $126.81M for 30.95 P/E if the $0.77 EPS becomes a reality. After $0.84 actual earnings per share reported by Verisk Analytics, Inc. for the previous quarter, Wall Street now forecasts -8.33% negative EPS growth.

Ratings analysis reveals 0 of Verisk Analytics’s analysts are positive. Out of 4 Wall Street analysts rating Verisk Analytics, 0 give it “Buy”, 0 “Sell” rating, while 4 recommend “Hold”. The lowest target is $88.0 while the high is $88.0. The stock’s average target of $88 is -7.69% below today’s ($95.33) share price. VRSK was included in 4 notes of analysts from August 26, 2016. As per Wednesday, January 18, the company rating was downgraded by Morgan Stanley. Macquarie Research initiated it with “Neutral” rating and $88.0 target in Friday, August 26 report. The company was downgraded on Wednesday, February 15 by Susquehanna. The firm has “Sector Perform” rating given on Friday, January 20 by RBC Capital Markets.

Wedgewood Partners Inc holds 3.97% of its portfolio in Verisk Analytics, Inc. for 1.40 million shares. Martin Investment Management Llc owns 136,687 shares or 3.18% of their US portfolio. Moreover, Riverpark Advisors Llc has 3.18% invested in the company for 290,000 shares. The Virginia-based Akre Capital Management Llc has invested 3.14% in the stock. Df Dent & Co Inc, a Maryland-based fund reported 1.44 million shares.

Atalanta Sosnoff Capital Llc increased Home Depot Inc (NYSE:HD) stake by 2,472 shares to 437,048 valued at $71.48 million in 2017Q3. It also upped Fedex Corp (NYSE:FDX) stake by 2,605 shares and now owns 204,418 shares. Honeywell Intl Inc (NYSE:HON) was raised too.

Investors sentiment increased to 1.04 in Q3 2017. Its up 0.01, from 1.03 in 2017Q2. It improved, as 33 investors sold BSX shares while 166 reduced holdings. 43 funds opened positions while 164 raised stakes. 1.21 billion shares or 1.08% less from 1.22 billion shares in 2017Q2 were reported. Trust Of Vermont invested in 4,221 shares. Thompson Davis & Com holds 0.53% or 10,179 shares in its portfolio. 10,164 were accumulated by Diligent Invsts Ltd Company. National Bank & Trust Of America De has 9.66 million shares. Moreover, Brown Advisory Inc has 0.01% invested in Boston Scientific Corporation (NYSE:BSX). Utah Retirement Systems reported 251,005 shares. Bluestein R H has invested 0.13% in Boston Scientific Corporation (NYSE:BSX). Orbimed Advisors Ltd Company holds 3.73% or 13.40 million shares. Palisade Asset Management Lc reported 11,900 shares or 0.06% of all its holdings. Private Tru Na holds 0.3% or 47,737 shares. Yhb reported 0.05% stake. State Board Of Administration Of Florida Retirement Sys has invested 0.16% in Boston Scientific Corporation (NYSE:BSX). Columbia Prtnrs L L C Mngmt, Maryland-based fund reported 129,484 shares. Peddock owns 7,250 shares. Federated Pa holds 0.24% of its portfolio in Boston Scientific Corporation (NYSE:BSX) for 2.90M shares.

Since August 1, 2017, it had 0 insider buys, and 10 sales for $14.38 million activity. 347,137 shares were sold by Bose Supratim, worth $10.11 million. On Friday, September 1 the insider Pratt Timothy A. sold $277,475. Another trade for 7,900 shares valued at $208,328 was made by Sorenson John Bradley on Wednesday, August 2. 57,031 shares were sold by Nanavaty Maulik, worth $1.56M. $440,547 worth of stock was sold by Phalen Michael P. on Monday, October 30. 12,433 shares valued at $332,584 were sold by Carruthers Wendy on Thursday, August 3.

Among 28 analysts covering Boston Scientific Corporation (NYSE:BSX), 23 have Buy rating, 0 Sell and 5 Hold. Therefore 82% are positive. Boston Scientific Corporation has $36 highest and $19 lowest target. $28.55’s average target is 13.75% above currents $25.1 stock price. Boston Scientific Corporation had 80 analyst reports since July 27, 2015 according to SRatingsIntel. The stock of Boston Scientific Corporation (NYSE:BSX) earned “Hold” rating by Jefferies on Tuesday, September 5. The firm has “Buy” rating given on Sunday, September 6 by BTIG Research. The stock has “Buy” rating by RBC Capital Markets on Tuesday, May 30. The rating was maintained by Stifel Nicolaus on Thursday, October 26 with “Buy”. Jefferies maintained Boston Scientific Corporation (NYSE:BSX) rating on Friday, July 28. Jefferies has “Hold” rating and $2800 target. The firm has “Buy” rating given on Wednesday, November 29 by BMO Capital Markets. As per Monday, October 5, the company rating was downgraded by Raymond James. Needham maintained it with “Buy” rating and $32.0 target in Thursday, October 26 report. The rating was initiated by SunTrust with “Buy” on Thursday, February 25. The stock of Boston Scientific Corporation (NYSE:BSX) earned “Buy” rating by Cowen & Co on Thursday, July 27.

Analysts await Boston Scientific Corporation (NYSE:BSX) to report earnings on February, 1. They expect $0.34 earnings per share, up 13.33% or $0.04 from last year’s $0.3 per share. BSX’s profit will be $466.88M for 18.46 P/E if the $0.34 EPS becomes a reality. After $0.31 actual earnings per share reported by Boston Scientific Corporation for the previous quarter, Wall Street now forecasts 9.68% EPS growth.